Tanezumab relieves moderate to severe pain due to Osteoarthritis (OA) of the knee: A phase 2 trial

被引：0
|
作者：
Lane, Nancy E. [1 ]
Schnitzer, Thomas J. [2 ]
Smith, Michael D. [3 ]
Brown, Mark T. [3 ]
机构：
[1] Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA
[2] Northwestern Univ, Chicago, IL 60611 USA
[3] Pfizer Inc, New London, CT USA
来源：
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S896 / S897
页数：2
相关论文
共 50 条
  • [31] Factors associated with pain severity reporting in knee osteoarthritis (OA).
    Creamer, P
    LethbridgeCeiku, M
    Hochberg, M
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 1234 - 1234
  • [32] The effects of vitamin C intake on pain in knee osteoarthritis (OA)
    Baker, K
    Niu, JB
    Goggins, J
    Clancy, M
    Felson, D
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S422 - S422
  • [33] Changes in synovitis are associated with changes in pain in knee osteoarthritis (OA).
    Hill, CL
    Hunter, DJ
    Niu, JB
    Clancy, M
    Guermazi, A
    Genant, H
    Felson, DT
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S71 - S71
  • [34] Productivity benefits from controlled-release vs short acting opioids for treatment of persistent moderate to severe osteoarthritis (OA) pain of the hip/knee
    Marshall, DA
    Strauss, ME
    Pericak, D
    Buitendyk, M
    Codding, C
    Torrance, G
    VALUE IN HEALTH, 2005, 8 (06) : A24 - A25
  • [35] Pooled analysis of tanezumab efficacy and safety with subgroup analyses of phase III clinical trials in patients with osteoarthritis pain of the knee or hip
    Tive, Leslie
    Bello, Alfonso E.
    Raclin, David
    Schnitzer, Thomas J.
    Nguyen, Ha
    Brown, Mark T.
    West, Christine R.
    JOURNAL OF PAIN RESEARCH, 2019, 12 : 975 - 995
  • [36] Efficacy and safety of tanezumab, NSAIDs, and placebo in patients with moderate to severe hip or knee osteoarthritis and a history of depression, anxiety, or insomnia: post-hoc analysis of phase 3 trials
    Mease, Philip
    Kuritzky, Louis
    Wright, Wendy L.
    Mallick-Searle, Theresa
    Fountaine, Robert
    Yang, Ruoyong
    Sadrarhami, Mojgan
    Faison, Warachal
    Johnston, Elizabeth
    Viktrup, Lars
    CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (11) : 1909 - 1922
  • [37] WOMAC Meaningful Within-patient Change: Results From 3 Studies of Tanezumab in Patients With Moderate-to-severe Osteoarthritis of the Hip or Knee
    Conaghan, Philip G.
    Dworkin, Robert H.
    Schnitzer, Thomas J.
    Berenbaum, Francis
    Bushmakin, Andrew G.
    Cappelleri, Joseph C.
    Viktrup, Lars
    Abraham, Lucy
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (06) : 615 - 621
  • [38] A placebo- and active-controlled trial of oxymorphone extended release for moderate-to-severe pain in osteoarthritis of the knee or hip.
    Matsumoto, A
    Babul, N
    Ahdieh, H
    Ma, T
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S75 - S75
  • [39] Onset and maintenance of efficacy of subcutaneous tanezumab in patients with moderate to severe osteoarthritis of the knee or hip: A 16-week dose-titration study
    Schnitzer, Thomas J.
    Khan, Arifulla
    Bessette, Louis
    Davignon, Isabelle
    Brown, Mark T.
    Pixton, Glenn
    Prucka, William R.
    Tive, Leslie
    Viktrup, Lars
    West, Christine R.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2020, 50 (03) : 387 - 393
  • [40] Supervised exercise plus acupuncture for moderate to severe knee osteoarthritis: a small randomised controlled trial
    Soni, Anushka
    Joshi, Abhay
    Mudge, Nicola
    Wyatt, Matthew
    Williamson, Lyn
    ACUPUNCTURE IN MEDICINE, 2012, 30 (03) : 176 - 181
12345